Cited by 24Treatment of Major DepressionElectroconvulsive Therapy StudiesSchizophrenia research and treatment

Benztropine in the Treatment of Venlafaxine-Induced Sweating

Open access
Garber, Aaron, Gregory, Robert J.·1997·The Journal of Clinical Psychiatry

Abstract

Article AbstractLetter to the Editor Sir: Sweating is a relatively common side effect seen with serotonin selective reuptake inhibitors (SSRIs) and has been reported in 7% to 11% of patients treated with SSRIs and 12% of patients treated with venlafaxine, an antidepressant with the ability to inhibit the reuptake of serotonin and norepinephrine. The following case indicates that this side effect can cause severe social disruption and limit effective treatment of depression. A possible management strategy is also suggested.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4088/jcp.v58n0407e

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 26 references couldn’t be matched to a known paper.

Research works printed but not linked: 17

  1. Sandyk R, Iacono RP, Crinnian C, et al. Effects of naltrexone in Tourette's syndrome [abstract]. Ann Neurol 1986;20:437
  2. Meuldijk R, Colon EJ. Methadone treatment of Tourette's disorder [let- ter]. Am J Psychiatry 1992;149:139-140
  3. McConville BJ, Norman AB, Fogelson MH, et al. Sequential use of opioid antagonists and agonists in Tourette's syndrome [letter]. Lancet 1994;343:601
  4. Lee CR, McTavish D, Sorkin EM. Tramadol: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs 1993;46:313-340
  5. Cohen DJ, Leckman JF, Shaywitz BA. The Tourette syndrome and other tics. In: Shaffer D, Ehrhardt AA, Greenhill LL, eds. The Clinical Guide to Child Psychiatry. New York, NY: The Free Press; 1985:3-28
  6. Gerfen CR, Engber TM, Mahan LC, et al. D 1 and D 2 dopamine recep- tor-regulated gene expression of striatonigral and striatopallidal neu- rons. Science 1990;250:1429-1432
  7. Hain JD, Smith BM, Stevenson I. Effectiveness and process of inter- viewing with drugs. J Psychiatr Res 1966;4:95-106
  8. McCall WV, Shelp FE, McDonald WM. Controlled investigation of the amobarbital interview for catatonic mutism. Am J Psychiatry 1992;149:202-206 REFERENCES
  9. Paroxetine hydrochloride. Physicians' Desk Reference. Montvale, NJ: Medical Economics; 1997:2681-2686
  10. Frost L, Lal S. Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors [letter]. Am J Psychiatry 1995;152:810
  11. Gordon TR, Goldstein JM, Waxman SG. Sensory abnormalities of the limbs and trunk. In: Bradley WG, Daroff RB, Fenichel GM, et al, eds. Neurology in Clinical Practice: Principles of Diagnosis and Manage- ment. 2nd ed. Boston, Mass: Butterworth-Heinemann; 1996:401
  12. Feder R. Clonidine treatment of excessive sweating [letter]. J Clin Psychiatry 1995;56:35
  13. Butt MM. Managing antidepressant-induced sweating [letter]. J Clin Psychiatry 1989;50:146-147
  14. Stein DJ, Hollander E. Obsessive-compulsive spectrum disorders [let- ter]. J Clin Psychiatry 1995;56:265-266
  15. Martin LJ, Spicer DM, Lewis MH, et al. Social deprivation of infant monkeys alters the chemoarchitecture of the brain, I: subcortical re- gions. J Neurosci 1991;11:3344-3358
  16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psy- chiatric Association; 1994:244
  17. Haller E, McNiel DE, Binder RL. Impact of a smoking ban and locked psychiatric unit. J Clin Psychiatry 1996;57:329-332

Cited by

Sorted by citations

Authors
Garber, A., & Gregory, R. J.
Venue
The Journal of Clinical Psychiatry
Published
1997-04-15
Volume
58
Issue
4
Pages
176-177
ISSN
0160-6689 (ISSN-L)
OpenAlex
W2010209221
Cited by
24
References
26
Citations by year
2026: 1 · 2025: 1 · 2023: 1 · 2018: 1 · 2014: 2 · 2013: 4 · 2012: 1
FWCI
0.84
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
benztropine, venlafaxine, sweating, serotonin reuptake inhibitors, antidepressant side effects, anticholinergic agents, depression treatment, norepinephrine reuptake inhibition
MeSH terms
Venlafaxine Hydrochloride, Benztropine, Cyclohexanols, Depressive Disorder, Female, Humans, Hyperhidrosis, Middle Aged, Sweating, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review